Sign up to save your podcasts
Or
Share Gene Therapy in Patients with Limb-Girdle Muscular Dystrophy Type 2E
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gene Therapy in Patients with Limb-Girdle Muscular Dystrophy Type 2E
Dr. Louise Rodino-Klapac discusses her abstract, "Safety, β-sarcoglycan Expression and Functional Outcomes from Systemic Gene Transfer of rAAVrh74.MHCK7.SGCB in Patients with Limb-Girdle Muscular Dystrophy Type 2E (LGMD2E)".
You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Louise Rodino-Klapac discusses her abstract, "Safety, β-sarcoglycan Expression and Functional Outcomes from Systemic Gene Transfer of rAAVrh74.MHCK7.SGCB in Patients with Limb-Girdle Muscular Dystrophy Type 2E (LGMD2E)".
You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
More shows like Neurology Minute
View all
JAMA Editors' Summary
129 Listeners
Neurology® Podcast
287 Listeners
NEJM This Week
315 Listeners
Practical Neurology Podcast
36 Listeners
JAMA Clinical Reviews
485 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
83 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
184 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
508 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
181 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
77 Listeners